Sports Editas Medicine Analysts Set Price Target at $5.00 Amid Mixed Ratings Shares of Editas Medicine, Inc. (NASDAQ:EDIT) have garnered a consensus price target of $5.00 from analysts covering the stock, as reported by MarketBeat Ratings.... Editorial6 January, 2026